#05 Matt Kaeberlein | Aging Interventions - Rapamycin, mTOR, CR, Sirtuins, NAD+ & Dog Aging Project
Live Longer World
00:00
Is There a Funding Mechanism to Accelerate Clinical Trials in Geroscience?
Matt Greene: I think this is a really exciting time as we've sort of already talked about in the field because there's so much interest. He says he would like to see people really starting to find ways to affect aging that are not incremental. Greene: We just don't have funding mechanisms that can fund important clinical trials right now in geroscience.
Transcript
Play full episode
